Gynecologic Cancer Care

NYU Langone’s doctors are leaders in the treatment of gynecologic cancer and offer the most sophisticated diagnostic tools and advanced surgical approaches to achieve the best outcomes.

As part of Perlmutter Cancer Center, our gynecologic oncologists specialize in robotic-assisted surgery, minimally invasive surgery, and complex surgical plans to remove more advanced cancers. We also specialize in surgery that removes cancer while preserving a woman’s fertility.

 Dr. Leslie R. Boyd

Dr. Leslie R. Boyd is a gynecologic oncologist who provides treatment for cancers of the reproductive tract, including endometrial, ovarian, and cervical cancer.

Our doctors work with imaging specialists, genetic counselors, reproductive medicine specialists, radiation oncologists, and rehabilitation specialists to care for women with gynecologic cancers, including the following:

  • cervical cancer
  • endometrial cancer, also called uterine cancer
  • gestational trophoblastic neoplasia, a rarely occurring tumor that can form in the uterus during pregnancy
  • ovarian and fallopian tube cancer
  • peritoneal cancer, which develops in a thin layer of tissue lining the inside of the abdomen
  • vaginal cancer
  • vulvar cancer

Advanced Approaches to Diagnosis

We use the latest imaging technology and diagnostic testing to help guide our surgical, medical, and radiation therapy plans. We have dedicated gynecologic radiologists reading our ultrasound and MRI scans; they image the ovaries and fallopian tubes, cervix, uterus, and other areas of the pelvis to find signs of gynecologic cancer.

Our pathologists are highly skilled at detecting precancerous and cancerous changes in biopsy tissue and can help determine the risk of a tumor growing and spreading. This information guides personalized treatment plans for each patient.

Sophisticated Surgical Care and Treatment Expertise

Our gynecologic oncologists are experts in minimally invasive surgery, including robotic-assisted procedures, to remove uterine, ovarian, fallopian, and peritoneal tumors, and some cervical cancers. Robotic-assisted surgery typically results in smaller scars, less postoperative bleeding, and a shorter healing time.

Fertility-sparing surgery and surgical procedures to reduce the risk of some gynecologic cancers are also offered by our experts.

Our gynecologic oncologists may prescribe chemotherapy and other medications as part of an overall treatment plan. Highly targeted radiation therapy that destroys cancer cells and minimizes treatment side effects may also be beneficial, depending on the type of cancer.

Screening, Prevention, and Risk-Reduction Strategies

Our doctors offer screening programs for some forms of gynecologic cancer to help diagnose the condition early, when treatment is most effective. We also provide prevention and risk-reduction strategies to help deter the development of cancer.

We offer genetic testing and counseling to help women understand their risk of developing ovarian cancer. Our gynecologic oncologists and genetic counselors are available to guide women through their ovarian cancer screening and risk-reduction options.

Cervical cancer screening programs, prevention strategies, and treatments for precancerous conditions of the cervix are also available.

Support Services

Our gynecologic oncologists refer patients to services such as pelvic rehabilitation and occupational and physical therapy, during and after treatment, to help maintain or regain muscle tone and strength.

Palliative care specialists, massage and Reiki therapists, acupuncturists, and nutritionists can also help people feel better during and after treatment. One-on-one psychological counseling and support groups are also available.

Access to Clinical Trials

Our patients have access to clinical trials at Perlmutter Cancer Center. We are one of the leading clinical trial teams in the country for gynecologic cancers. We offer numerous studies of ovarian, endometrial, and cervical cancer treatments, including new targeted medications. We are also a leader in clinical trials for ovarian cancer prevention in women who are at high risk to develop cancer.